Precision in Pharma Marketing: How AI & ML Helps Overcome Data Latency & Drive Physician Engagement
Blogs About
Supporting HCPs in Care Delivery
Synchronize HCP and DTC Marketing Through Patient Centricity
Enhancing Patient Outcomes: Aligning HCP and DTC Strategies
AI Isn’t Enough: Human Intelligence Is Still Key in Pharma Marketing
It can feel like we are drowning in companies pushing AI capabilities or embedding AI in their apps, and that’s just what we see on the surface. Our reactions run the gamut —...
The Second Pillar of Next-Best Action: Aligning to the Patient Journey
In the first installment of our series on the Four Pillars of Next-Best-Action Success, we explored Pillar 1: Omnichannel Integration, and the importance of reaching...
Are You Seeing These Red Flags in Your Pharma Marketing?
In the excitement that follows every new trend in pharmaceutical marketing, it’s easy to lose sight of the bedrock principles that drive impact and ROI. Here are four red...
Four Pillars for Better Pharma Advertising: Omnichannel Integration
Next-best-action (NBA) marketing is the future of pharma advertising – capitalizing on today’s ample data resources and technology advancements to deliver more targeted,...
OptimizeRx Predictions: 2024 Pharma Marketing Trends
The past few years have been a whirlwind for pharma marketing. AI, real-world data, and omnichannel strategies have exploded, transforming how we reach doctors and patients....
OptimizeRx + Medicx: Looking Ahead to Better Pharmaceutical Marketing
The end of the year is often a time for reflection, as we think back on our experiences, learnings, successes, and setbacks. But it’s also an occasion to visualize next...
Insights from MedDev: Omnichannel Marketing Solutions for Medtech Brands
Next-Best Action: Elevating the Future of Omnichannel HCP Marketing
Terms like omnichannel, artificial intelligence (AI), data-driven, and real time are defining the conversation around HCP marketing – and for good reason. Today’s savviest...
Physicians Speak: Make Pharma Digital Marketing Clinically Relevant
Pharma and MedTech companies continue to spend billions marketing drugs and devices to physicians. In fact, according to Forbes, pharma spent nearly $4 billion on advertising...
Insulin Price Drops – Enough for Diabetes Patients to Manage Costs?
Diabetes continues to plague the healthcare industry, maintaining its status as one of the top public health issues in terms of clinical outcomes and cost. The American...